Exploratory Study of Xolair in Chronic Obstructive Pulmonary Disease in Patients With Elevated IgE Levels

NCT00851370 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Unable to find eligible subjects- study closed

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG: Omalizumab (Xolair)
DRUG: Placebo

Sponsor

National Jewish Health

Collaborators

[object Object]